Clinical Laboratory Price Transparency Act of 2023
December 17, 2024
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Currently IN_COMMITTEE. The next step in the legislative lifecycle is Floor Vote.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
This legislation aims to standardize how Medicare patients access pricing information for diagnostic tests, potentially affecting out-of-pocket costs and provider billing practices for laboratories nationwide.
Potentially affected actors named in the source documents. Mention is not a position.
Clinical laboratories
These entities must publish price lists and are subject to potential civil monetary penalties for non-compliance.
Medicare beneficiaries
These individuals gain access to public pricing information for diagnostic tests.
Group health plans
These plans may have their negotiated rates with laboratories disclosed publicly if required by the Secretary.
Current stage: IN_COMMITTEE.
Floor Vote.
Background
- Mrs. Miller is a member of the U.S. House of Representatives representing West Virginia. context
- The Social Security Act is the foundational federal law that established the Medicare program. context
Summary
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
When do laboratories have to start posting their prices?
What happens if a laboratory does not post its prices?
Can the government waive these penalties?
Why It Matters
This legislation aims to standardize how Medicare patients access pricing information for diagnostic tests, potentially affecting out-of-pocket costs and provider billing practices for laboratories nationwide.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Expansion of Price Transparency
This bill extends the logic of hospital price transparency rules to the clinical laboratory sector, specifically targeting Medicare-covered diagnostic tests.
Connected Entities
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools